Inflammatory Bowel Disease(IBD)Database

NCT01266538 | Not Yet Recruiting

• 1 other identifier: TASMC-10-ID-467-CTIL
• Study Type: observational
• Target: 2,500
• Locations: 1 country
• Sites: 1

Brief Summary

This will be a comprehensive epidemiological, clinical, endoscopic and histological database for inflammatory bowel diseases patients in our medical center that will further provide clinical and basic investigations.

Conditions

Inflammatory Bowel Disease

Outcome Measures

Primary Outcomes (1)

• flactuations in gastrointestinal inflammation

  ongoing, up to 4 times a year

Secondary Outcomes (1)

• development of IBD-related morbidity and complications over time

  ongoing, up to 4 times a year

Study Arms (3)

IBD patients

Patients diagnosed with Inflammatory Bowel Disease (IBD)

patients after a Large Bowel Resection

Patients after a Large Bowel Resection, with or without a pouch.

Control group

Family members of IBD patients, Patients with Irritable Bowel Syndrome (IBS), Fap (familial polyposis)patients after a large bowel resection, Patient performing screening endoscopy

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

1. Cases: Patients diagnosed with Inflammatory Bowel Disease (IBD) attending the departement of Gastroenterology (Tel Aviv Sourasky Medical Center) for a regular follow up / treatment. 2. Controls:Family members of IBD patients, Patients with Irritable Bowel Syndrome (IBS), Fap (familial polyposis)patients after a large bowel resection, Patient performing screening endoscopy \--------------------------------------------------------------------------------

You may qualify if:

• Diagnosis of IBD Regular treatment and follow up in Tel Aviv Sourasky medical center Fap (familial polyposis)patients after a large bowel resection, as controls Family members of IBD patients as controls Patients with Irritable Bowel Syndrome (IBS), as controls -

You may not qualify if:

• pregnancy age\<18 years

Sponsors & Collaborators

• Tel-Aviv Sourasky Medical Center: lead

Study Sites (1)

Tel Aviv Sourasky Medical Center

Tel Aviv, 64239, Israel

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

blood serum, gastrointestinal biopsies, fecal samples

MeSH Terms

Conditions

Inflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

Gastroenteritis; Gastrointestinal Diseases; Digestive System Diseases; Intestinal Diseases

Study Officials

• Iris Dotan, MD PhD

  Tel-Aviv Sourasky Medical Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Iris Dotan, MD PhD

CONTACT

972-3-6947305; irisd@tasmc.health.gov.il

Study Design

• Study Type: observational
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER GOV

Study Record Dates

• First Submitted: December 23, 2010
• First Posted: December 24, 2010
• Study Start: January 1, 2011
• Primary Completion (Estimated): December 1, 2026
• Study Completion (Estimated): December 1, 2026
• Last Updated: December 24, 2010

Record last verified: 2010-12

Locations

IL (1)